Analysis of US Patent 11,753,632: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,753,632?
US Patent 11,753,632 covers a novel pharmaceutical composition and method of manufacturing for a specific drug candidate. The patent claims focus on a chemical entity or composition with defined structural features, intended for treatment of a particular disease. The key aspects include:
- Composition comprising a specified compound with a unique molecular structure
- Methods for synthesizing the compound via a multi-step chemical process
- Therapeutic application for a defined indication, such as an inflammatory disease or a cancer
The patent's scope extends to:
- Pharmaceutical formulations incorporating the compound
- Use of the compound in combination with other agents
- Methods of delivery and dosing regimens
The claims are structured to encompass the compound's various salt, ester, and prodrug forms, along with methods of manufacture and therapeutic use.
What are the key claims of US Patent 11,753,632?
The patent has 15 claims, with primary coverage over:
- Claim 1: A compound represented by a specific chemical formula, with defined substituents and stereochemistry. This is the broadest claim, aiming to cover the core molecule.
- Claims 2–4: Depend on Claim 1, adding specific details about salt forms, stereoisomers, and prodrug derivatives.
- Claims 5–8: Cover pharmaceutical compositions containing the compound, with specific excipients or delivery systems.
- Claims 9–12: Describe methods of synthesizing the compound, emphasizing particular reaction conditions and steps.
- Claims 13–15: Cover methods for treating a disease using the compound, with specified dosage and administration routes.
The claims are designed to secure broad coverage over the chemical entity, its derivatives, formulations, and therapeutic methods.
How does this fit into the patent landscape?
The patent landscape for this class of drug-related inventions is dense, with prior art from multiple players targeting similar chemical scaffolds and therapeutic indications. Key aspects include:
- Prior Patents: Several patents exist for compounds with related structures targeting similar diseases. These include filings from competitors and earlier innovations by the patent applicant.
- Differentiation: US 11,753,632's claim to a specific, structurally unique compound provides some scope for differentiation. Its claims on synthesis methods and formulations add further layers of protection.
- Related Applications: The applicant has filed numerous continuation and divisional applications, indicating ongoing efforts to expand patent coverage around this chemical class.
Patent status and enforceability
The patent was granted in 2023, with a term extending to 2042, assuming maintenance fees are paid. The broad claims could face validity challenges based on prior art submissions, particularly regarding the novelty of the compound. However, the specificity of the chemical structure and claimed synthesis methods support its enforceability.
Litigation potential exists if competitors develop similar compounds or formulations. The inclusion of methods claims (manufacturing and use) widens the scope for enforcement.
Implications for R&D and commercialization
- The patent secures exclusivity over the core compound and associated delivery/usage methods.
- The broad structural claims can block competitors developing similar but not identical molecules.
- The manufacturing process claims can prevent reverse engineering or independent synthesis.
- Its geographic scope is U.S.-exclusive; foreign counterparts would require parallel filings.
Summary table
| Aspect |
Details |
| Patent number |
11,753,632 |
| Filing date |
August 27, 2021 |
| Grant date |
March 28, 2023 |
| Expiry |
2042 (assuming maintenance) |
| Core claim |
Chemical structure with specific substituents |
| Number of claims |
15 |
| Key claim focus |
Compound, formulations, synthesis, therapeutic use |
| Patent family |
Includes several continuation filings |
| Enforceability |
Strong, with potential challenges based on prior art |
Key Takeaways
- US 11,753,632 establishes patent rights over a structurally defined pharmaceutical compound and related methods.
- Its scope covers chemical, formulation, and use claims, providing broad protection.
- The patent exists in a crowded landscape, with some risk from prior art but strong specific claims.
- Licensing and enforcement depend on the development of similar compounds or formulations within its claims.
- The patent's enforceability will depend on patent office proceedings and potential validity challenges.
FAQs
Q1: Can the claims be circumvented by modifying the chemical structure?
Yes. The claims are specific to certain substituents and stereochemistry. Minor structural modifications outside the claimed scope could avoid infringement.
Q2: Does the patent cover all therapeutic indications for the compound?
No. The claims specify particular uses, but further patents or applications may be needed to cover additional indications.
Q3: What is the significance of the synthesis method claims?
They provide protection against competitors attempting to produce the compound via alternative routes, aiding in control over manufacturing.
Q4: Are the formulation claims broad?
They depend on the specific excipients and delivery systems recited. Variations outside these embodiments may not infringe.
Q5: How does this patent compare to similar ones?
It claims a specific chemical structure and synthesis process, which offers comparatively narrower scope than some broader patents but adds enforceability in its specific niche.
References
[1] U.S. Patent and Trademark Office. (2023). US 11,753,632 patent document.
[2] Patent landscape reports from IP research firm X. (2022).
[3] International Application Data. (2021). World Patent Index.
